These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 34074070)
1. High Concordance of Genomic Profiles between Primary and Metastatic Colorectal Cancer. Lee SE; Park HY; Hwang DY; Han HS Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074070 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer. Furuki H; Yamada T; Takahashi G; Iwai T; Koizumi M; Shinji S; Yokoyama Y; Takeda K; Taniai N; Uchida E Eur J Surg Oncol; 2018 Jul; 44(7):975-982. PubMed ID: 29452859 [TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles. Vignot S; Lefebvre C; Frampton GM; Meurice G; Yelensky R; Palmer G; Capron F; Lazar V; Hannoun L; Miller VA; André F; Stephens PJ; Soria JC; Spano JP Eur J Cancer; 2015 May; 51(7):791-9. PubMed ID: 25797355 [TBL] [Abstract][Full Text] [Related]
4. Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance. Heczko L; Liška V; Vyčítal O; Fiala O; Šůsová S; Hlaváč V; Souček P Hum Genomics; 2024 Jul; 18(1):83. PubMed ID: 39030589 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization. Escobar D; Bushara O; Sun L; Liao J; Yang GY Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891 [TBL] [Abstract][Full Text] [Related]
6. Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort. Aparicio T; Svrcek M; Henriques J; Afchain P; Lièvre A; Tougeron D; Gagniere J; Terrebonne E; Piessen G; Legoux JL; Lecaille C; Pocard M; Gornet JM; Zaanan A; Lavau-Denes S; Lecomte T; Deutsch D; Vernerey D; Puig PL Int J Cancer; 2021 Apr; 148(7):1731-1742. PubMed ID: 33186471 [TBL] [Abstract][Full Text] [Related]
7. Mutation profiling of cancer drivers in Brazilian colorectal cancer. Dos Santos W; Sobanski T; de Carvalho AC; Evangelista AF; Matsushita M; Berardinelli GN; de Oliveira MA; Reis RM; Guimarães DP Sci Rep; 2019 Sep; 9(1):13687. PubMed ID: 31548566 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas. Lee SM; Sung CO Sci Rep; 2021 Mar; 11(1):6203. PubMed ID: 33737597 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomas. Yoshioka Y; Togashi Y; Chikugo T; Kogita A; Taguri M; Terashima M; Mizukami T; Hayashi H; Sakai K; de Velasco MA; Tomida S; Fujita Y; Tokoro T; Ito A; Okuno K; Nishio K Cancer; 2015 Dec; 121(24):4359-68. PubMed ID: 26488212 [TBL] [Abstract][Full Text] [Related]
10. Next-Generation Sequencing of Matched Primary and Metastatic Rectal Adenocarcinomas Demonstrates Minimal Mutation Gain and Concordance to Colonic Adenocarcinomas. Crumley SM; Pepper KL; Phan AT; Olsen RJ; Schwartz MR; Portier BP Arch Pathol Lab Med; 2016 Jun; 140(6):529-35. PubMed ID: 26536055 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study. Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664 [TBL] [Abstract][Full Text] [Related]
12. Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer. Joung JG; Oh BY; Hong HK; Al-Khalidi H; Al-Alem F; Lee HO; Bae JS; Kim J; Cha HU; Alotaibi M; Cho YB; Hassanain M; Park WY; Lee WY Clin Cancer Res; 2017 Dec; 23(23):7209-7216. PubMed ID: 28939741 [No Abstract] [Full Text] [Related]
13. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing. Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406 [TBL] [Abstract][Full Text] [Related]
14. T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes. Mennonna D; Maccalli C; Romano MC; Garavaglia C; Capocefalo F; Bordoni R; Severgnini M; De Bellis G; Sidney J; Sette A; Gori A; Longhi R; Braga M; Ghirardelli L; Baldari L; Orsenigo E; Albarello L; Zino E; Fleischhauer K; Mazzola G; Ferrero N; Amoroso A; Casorati G; Parmiani G; Dellabona P Gut; 2017 Mar; 66(3):454-463. PubMed ID: 26681737 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer. Lieu CH; Golemis EA; Serebriiskii IG; Newberg J; Hemmerich A; Connelly C; Messersmith WA; Eng C; Eckhardt SG; Frampton G; Cooke M; Meyer JE Clin Cancer Res; 2019 Oct; 25(19):5852-5858. PubMed ID: 31243121 [TBL] [Abstract][Full Text] [Related]
16. Co-evolution of somatic variation in primary and metastatic colorectal cancer may expand biopsy indications in the molecular era. Kim R; Schell MJ; Teer JK; Greenawalt DM; Yang M; Yeatman TJ PLoS One; 2015; 10(5):e0126670. PubMed ID: 25974029 [TBL] [Abstract][Full Text] [Related]
17. Mutation Status of Kawaguchi Y; Kopetz S; Newhook TE; De Bellis M; Chun YS; Tzeng CD; Aloia TA; Vauthey JN Clin Cancer Res; 2019 Oct; 25(19):5843-5851. PubMed ID: 31221662 [TBL] [Abstract][Full Text] [Related]